Articolul precedent |
Articolul urmator |
300 1 |
Ultima descărcare din IBN: 2022-04-10 17:55 |
SM ISO690:2012 MOISEI, Tatiana, TĂNASE, Adrian. Extracorporeal treatment in acute kidney injury. In: Cercetarea în biomedicină și sănătate: calitate, excelență și performanță, Ed. 1, 20-22 octombrie 2021, Chişinău. Chișinău, Republica Moldova: 2021, p. 287. ISBN 978-9975-82-223-7 (PDF).. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Cercetarea în biomedicină și sănătate: calitate, excelență și performanță 2021 | ||||||
Conferința "Cercetarea în biomedicină și sănătate: calitate, excelență și performanță" 1, Chişinău, Moldova, 20-22 octombrie 2021 | ||||||
|
||||||
Pag. 287-287 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Background. The issue of improving the management of patients with IRA remains open. Although there is currently no effective pathogenetic treatment, the substitution of renal function by extracorporeal methods remains the only hope for survival of critically ill patients. Objective of the study. Study of the results of hemodialysis treatment of patients with Acute Renal Injury in the Hemodialysis and Renal Transplant Department of IMSP Republican Clinical Hospital "Timofei Moşneaga". Material and Methods. Material: A retrospective study was performed on a group of 80 patients with IRA, treated in the Hemodialysis and Renal Transplant Department of IMSP SCR "Timofei Moşneaga" during 2019-2020, including 60 patients with IRA in 2019 and 20 patients with IRA associated with COVID-19 infection during 2020. Methods: Meta-analysis; Statistical research method with average assessment. Results. The analysis of the results in the patient groups from 2019 and 2020 shows considerable changes in the efficiency of serum urea and creatinine treatment and, respectively, the lethality rate. The patients tested in 2019 had a decrease in urea to 19.5 mmol / l, compared to the value of 31.2 mmol before HD and creatinine decreased to 343 mkmol / l, compared to the initial value of 567 mkmol /it. Respectively, the lethality was 38%. A completely opposite result was obtained in patients with IRA associated with COVID-19, in which both urea and creatinine were constantly increasing, without positive dynamics, so the lethality reached 95%. Conclusion. The effectiveness of hemodialysis treatment is directly proportional to the general condition of the patients and the severity of the disease. The mortality rate in patients with IRA in the studied groups was 38% in 2019 and 95% in the group of patients with COVID-19 in 2020. |
||||||
Cuvinte-cheie Extracorporeal treatment, hemodialysis, acute renal injury, tratament extracorporeal, hemodializa, injurie renală acută. |
||||||
|